Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance. / von Eyben, Finn Edler; Madsen, Ebbe Lindegaard; Blaabjerg, Ole; Petersen, Per Hyltoft; Jacobsen, Grete Krag; Specht, Lena; Pedersen, Bent Nørgaard; von der Maase, Hans.

I: Acta Oncologica, Bind 41, Nr. 1, 2002, s. 77-83.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

von Eyben, FE, Madsen, EL, Blaabjerg, O, Petersen, PH, Jacobsen, GK, Specht, L, Pedersen, BN & von der Maase, H 2002, 'Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance', Acta Oncologica, bind 41, nr. 1, s. 77-83.

APA

von Eyben, F. E., Madsen, E. L., Blaabjerg, O., Petersen, P. H., Jacobsen, G. K., Specht, L., Pedersen, B. N., & von der Maase, H. (2002). Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance. Acta Oncologica, 41(1), 77-83.

Vancouver

von Eyben FE, Madsen EL, Blaabjerg O, Petersen PH, Jacobsen GK, Specht L o.a. Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance. Acta Oncologica. 2002;41(1):77-83.

Author

von Eyben, Finn Edler ; Madsen, Ebbe Lindegaard ; Blaabjerg, Ole ; Petersen, Per Hyltoft ; Jacobsen, Grete Krag ; Specht, Lena ; Pedersen, Bent Nørgaard ; von der Maase, Hans. / Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance. I: Acta Oncologica. 2002 ; Bind 41, Nr. 1. s. 77-83.

Bibtex

@article{95970ef04c6f11df928f000ea68e967b,
title = "Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance",
abstract = "Serum lactate dehydrogenase isoenzyme I catalytic concentration (S-LD-1) was measured in patients with testicular seminoma clinical stage I followed with surveillance after orchiectomy. The serum samples were obtained before orchiectomy in 110 patients (group A) and soon after orchiectomy in 55 patients (group B). In group A, 60 patients (55%) had elevated S-LD-1 and 10 patients (9%) had elevated serum human chorionic gonadotropin concentrations (S-hCG). In group B, median S-LD-1 was lower than that of group A and decreased with increasing time after orchiectomv (p = 0.001, Jonckheere-Terpstra test, one-sided). After a median follow-up of 5.1 years, 23 patients (21%) in group A had relapses. The patients with elevated S-LD-1 and those with normal S-LD-1 had a similar relapse-free survival (p = 0.79, log-rank test). Thus patients with seminoma stage I had elevated S-LD-1 more often than elevated S-hCG but an elevation in S-LD-1 did not predict a relapse during follow-up with surveillance. Further studies are required to elucidate the value of S-LD-1 in monitoring the surveillance of patients with seminoma stage I.",
author = "{von Eyben}, {Finn Edler} and Madsen, {Ebbe Lindegaard} and Ole Blaabjerg and Petersen, {Per Hyltoft} and Jacobsen, {Grete Krag} and Lena Specht and Pedersen, {Bent N{\o}rgaard} and {von der Maase}, Hans",
note = "Keywords: Adult; Aged; Carcinoma; Chorionic Gonadotropin; Disease-Free Survival; Follow-Up Studies; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Preoperative Care; Seminoma; Spermatocytes; Survival Rate; Testicular Neoplasms; alpha-Fetoproteins",
year = "2002",
language = "English",
volume = "41",
pages = "77--83",
journal = "Acta Oncologica",
issn = "1100-1704",
publisher = "Taylor & Francis",
number = "1",

}

RIS

TY - JOUR

T1 - Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance

AU - von Eyben, Finn Edler

AU - Madsen, Ebbe Lindegaard

AU - Blaabjerg, Ole

AU - Petersen, Per Hyltoft

AU - Jacobsen, Grete Krag

AU - Specht, Lena

AU - Pedersen, Bent Nørgaard

AU - von der Maase, Hans

N1 - Keywords: Adult; Aged; Carcinoma; Chorionic Gonadotropin; Disease-Free Survival; Follow-Up Studies; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Preoperative Care; Seminoma; Spermatocytes; Survival Rate; Testicular Neoplasms; alpha-Fetoproteins

PY - 2002

Y1 - 2002

N2 - Serum lactate dehydrogenase isoenzyme I catalytic concentration (S-LD-1) was measured in patients with testicular seminoma clinical stage I followed with surveillance after orchiectomy. The serum samples were obtained before orchiectomy in 110 patients (group A) and soon after orchiectomy in 55 patients (group B). In group A, 60 patients (55%) had elevated S-LD-1 and 10 patients (9%) had elevated serum human chorionic gonadotropin concentrations (S-hCG). In group B, median S-LD-1 was lower than that of group A and decreased with increasing time after orchiectomv (p = 0.001, Jonckheere-Terpstra test, one-sided). After a median follow-up of 5.1 years, 23 patients (21%) in group A had relapses. The patients with elevated S-LD-1 and those with normal S-LD-1 had a similar relapse-free survival (p = 0.79, log-rank test). Thus patients with seminoma stage I had elevated S-LD-1 more often than elevated S-hCG but an elevation in S-LD-1 did not predict a relapse during follow-up with surveillance. Further studies are required to elucidate the value of S-LD-1 in monitoring the surveillance of patients with seminoma stage I.

AB - Serum lactate dehydrogenase isoenzyme I catalytic concentration (S-LD-1) was measured in patients with testicular seminoma clinical stage I followed with surveillance after orchiectomy. The serum samples were obtained before orchiectomy in 110 patients (group A) and soon after orchiectomy in 55 patients (group B). In group A, 60 patients (55%) had elevated S-LD-1 and 10 patients (9%) had elevated serum human chorionic gonadotropin concentrations (S-hCG). In group B, median S-LD-1 was lower than that of group A and decreased with increasing time after orchiectomv (p = 0.001, Jonckheere-Terpstra test, one-sided). After a median follow-up of 5.1 years, 23 patients (21%) in group A had relapses. The patients with elevated S-LD-1 and those with normal S-LD-1 had a similar relapse-free survival (p = 0.79, log-rank test). Thus patients with seminoma stage I had elevated S-LD-1 more often than elevated S-hCG but an elevation in S-LD-1 did not predict a relapse during follow-up with surveillance. Further studies are required to elucidate the value of S-LD-1 in monitoring the surveillance of patients with seminoma stage I.

M3 - Journal article

C2 - 11990523

VL - 41

SP - 77

EP - 83

JO - Acta Oncologica

JF - Acta Oncologica

SN - 1100-1704

IS - 1

ER -

ID: 19368805